Literature DB >> 11738614

Three-dimensional common-feature hypotheses for octopamine agonist 2-(arylimino)imidazolidines.

Akinori Hirashima1, Masako Morimoto, Eiichi Kuwano, Eiji Taniguchi, Morifusa Eto.   

Abstract

Three-dimensional pharmacophore hypotheses were built from a set of 10 octopamine (OA) agonist 2-(Arylimino)imidazolidines (AIIs), 2-(Arylimino)thiazolidines (AITs) and 2-(Arylimino)oxazolidines (AIOs). Among the 10 common-featured models generated by program Catalyst/HipHop, a hypothesis including a ring aromatic (RA), a positive ionizable (PI) and three hydrophobic aliphatic (HpAl) features was considered to be important in evaluating the OA-agonist activity. Active OA agonist 2,6-Et2 AII mapped well onto all the RA, PI and HpAl features of the hypothesis. On the other hand, less active compounds were shown to be difficult to achieve the energetically favorable conformation which is found in the active molecules in order to fit the 3-D common-feature pharmacophore models. Taken together, 2,6-Et2-Ph and foramidine structures are important as OA agonists. The present studies on OA agonists demonstrate that a RA, a PI and three HpAl sites located on the molecule seem to be essential for OA-agonist activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11738614     DOI: 10.1016/s0968-0896(01)00247-4

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Receptors of mammalian trace amines.

Authors:  Anita H Lewin
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Inhibitors of calling behavior of Plodia interpunctella.

Authors:  Akinori Hirashima; Yoko Shigeta; Tomohiko Eiraku; Eiichi Kuwano
Journal:  J Insect Sci       Date:  2003-01-17       Impact factor: 1.857

3.  Octopaminergic agonists for the cockroach neuronal octopamine receptor.

Authors:  Akinori Hirashima; Masako Morimoto; Eiichi Kuwano; Morifusa Eto
Journal:  J Insect Sci       Date:  2003-04-21       Impact factor: 1.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.